Ofatumumab Subcutaneous Administration in Subjects With Relapsing-Remitting Multiple Sclerosis (MIRROR) Clinicaltrials.gov, 2 Feb 2012 Accessed on 20 Feb 2012 from http://clinicaltrials.gov/ct2/show/NCT01457924. CommentRecommendBookmarkWatch